Protracted SARS‐CoV‐2 pneumonia with rituximab treatment: About two cases
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26921
Abstract: Here, we describe two patients, previously treated with rituximab, who presented with a protracted SARS-CoV-2 infection with an atypical course. We hypothesized an incomplete viral clearance with persistent pneumonia due to an impaired or delayed… read more here.
Keywords: pneumonia rituximab; cov pneumonia; rituximab treatment; sars cov ... See more keywords
Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology International"
DOI: 10.1007/s00296-019-04272-1
Abstract: Rituximab, an anti-CD20 monoclonal antibody causing selective B-cell depletion, is used for various systemic inflammatory and autoimmune diseases (SIADs). Long-term safety data on rituximab are limited. The objectives of this study were to evaluate the… read more here.
Keywords: rituximab treatment; long term; treatment; safety ... See more keywords
Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Nephrology"
DOI: 10.1007/s00467-021-05304-4
Abstract: Hypogammaglobulinemia is a major adverse event after rituximab treatment; however, the precise incidence and risk factors are unclear in complicated steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS) patients. This was a single-center, retrospective, observational study.… read more here.
Keywords: incidence; igg levels; risk factors; rituximab treatment ... See more keywords
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.
Sign Up to like & getrecommendations! Published in 2020 at "Autoimmunity reviews"
DOI: 10.1016/j.autrev.2020.102737
Abstract: OBJECTIVE We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS We performed a systematic literature review from the inception dates until July 20, 2020 for… read more here.
Keywords: rituximab; treatment; granulomatosis polyangiitis; rituximab treatment ... See more keywords
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis-A Single Center Experience.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of cardiac failure"
DOI: 10.1016/j.cardfail.2021.07.008
Abstract: OBJECTIVE To examine the effect of anti-B cell therapy (rituximab) on cardiac inflammation and function in corticosteroid-refractory cardiac sarcoidosis. BACKGROUND Cardiac sarcoidosis (CS) is a rare cause of cardiomyopathy characterized by granulomatous inflammation involving the… read more here.
Keywords: cardiac sarcoidosis; sarcoidosis; refractory cardiac; rituximab treatment ... See more keywords
The value of rituximab treatment in primary Sjögren's syndrome.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical immunology"
DOI: 10.1016/j.clim.2017.05.002
Abstract: The rationale for B cell depletion therapy with rituximab in primary Sjögren's syndrome relies upon the well-established role of B cell hyperactivity in immunopathogenesis. In line with this notion, several biomarkers of B cell activity… read more here.
Keywords: gren syndrome; treatment; primary gren; value rituximab ... See more keywords
IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-59651-7
Abstract: The interactions of antibodies with myeloid Fcγ receptors and the complement system are regulated by an Asn297-linked glycan in the Fc portion of IgG. Alterations of serum IgG-Fc glycosylation have been reported in various autoimmune… read more here.
Keywords: igg glycosylation; glycosylation; immune thrombocytopenia; rituximab treatment ... See more keywords
Rituximab treatment of ANCA-associated vasculitis
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1748597
Abstract: ABSTRACT Introduction Rituximab, an anti–B-cell biological therapy, has been investigated in several clinical trials on antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs). Areas covered In this paper, the clinical trials and open-label studies on rituximab efficacy… read more here.
Keywords: rituximab; treatment anca; rituximab treatment; anca ... See more keywords
Rituximab in the treatment of Susac's syndrome: Report of a case.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of ophthalmology"
DOI: 10.1177/1120672120924545
Abstract: SIGNIFICANCE Susac's syndrome is a rare retinocochleocerebral immune-mediated endotheliopathy and clinically manifests as a pathognomonic triad of encephalopathy, hearing loss, and branch retinal artery occlusion. This triad is rarely present at symptom onset, thus, it… read more here.
Keywords: treatment susac; treatment; susac syndrome; case ... See more keywords
Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/1756286419871187
Abstract: Background: The objective of this study was to evaluate the efficacy and safety of repeated low-dose rituximab treatment guided by monitoring circulating CD19+ B cells in patients with refractory myasthenia gravis (MG). Methods: Patients with… read more here.
Keywords: rituximab; dose rituximab; low dose; treatment ... See more keywords
Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i4.1454
Abstract: We presented a letter about a case of a 37-year-old Black female with a history of human immunodeficiency virus and an undetectable viral load. She was evaluated with weakness in the scapular (grade III) and… read more here.
Keywords: immunodeficiency virus; nemaline myopathy; rituximab treatment; human immunodeficiency ... See more keywords